190 related articles for article (PubMed ID: 6396565)
21. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine.
Joss RA; Goldberg RS; Yates JW
Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190
[TBL] [Abstract][Full Text] [Related]
23. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine(ACNU), and methotrexate (EACAM) in advanced adenocarcinoma of the lung].
Nakanishi F; Sugiishi M; Ogasawara T; Sugiura I; Kinoshita T; Ito Y; Hoshino A
Gan To Kagaku Ryoho; 1985 Jun; 12(6):1339-44. PubMed ID: 3859252
[TBL] [Abstract][Full Text] [Related]
24. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
[TBL] [Abstract][Full Text] [Related]
25. [Combination chemotherapy of primary adenocarcinoma of the lung using adriamycin, ACNU, and vindesine].
Yoneda S; Min KY; Honma T; Yoshida S; Nakagawa H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):961-6. PubMed ID: 6575723
[TBL] [Abstract][Full Text] [Related]
26. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
Taguchi T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
28. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
[TBL] [Abstract][Full Text] [Related]
29. [The treatment of psoriasis. Critical study of the use of ACNU (nimustine hydrochloride)].
Imaizumi T; Mitsuhashi Y; Katabira Y
Ann Dermatol Venereol; 1986; 113(5):427-34. PubMed ID: 3472485
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and therapeutic study (phase II) using VP-16/213 and methyl-CCNU in patients with inoperable, recurring or metastasizing carcinomas of the gastriointestinal tract].
Hartmann D; Obrecht JP; Stalder GA
Onkologie; 1978 Oct; 1(5):201-6. PubMed ID: 366488
[TBL] [Abstract][Full Text] [Related]
31. Methyl-CCNU and methotrexate therapy in patients with advanced colorectal cancer after failure of 5-fluorouracil chemotherapy.
Zorzitto ML; Myers R; Bazos MJ; Shepherd FA; Evans WK
Am J Clin Oncol; 1986 Feb; 9(1):27-30. PubMed ID: 3953490
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced gastrointestinal malignancy.
Vaughn CB; Chapman JL; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Brady PR
Oncology; 1981; 38(3):129-33. PubMed ID: 7010257
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) of glioma cells in vivo and in vitro.
Yoshida J; Shibuya N; Kobayashi T; Kageyama N
Cancer; 1982 Aug; 50(3):410-8. PubMed ID: 6953989
[TBL] [Abstract][Full Text] [Related]
34. Therapy of advanced gastrointestinal cancer with the nitrosoureas.
Moertel CG
Cancer Chemother Rep 3; 1973 May; 4(3):27-34. PubMed ID: 4748872
[No Abstract] [Full Text] [Related]
35. Chemotherapy with tauromustine in advanced non-small cell lung cancer. A trial of the Phase II Study Group of the Association for Medical Oncology of the German Cancer Society.
Gatzemeier U; Drings P; Edler L; Fiebig HH; Hinke A; Rieche K; Tessen HW
Onkologie; 1990 Jun; 13(3):186-8. PubMed ID: 2168534
[TBL] [Abstract][Full Text] [Related]
36. [ACNU delivery to malignant tumor tissue and serum--route of administration and combined use of phenobarbital].
Muraoka K
No To Shinkei; 1983 Dec; 35(12):1199-206. PubMed ID: 6584117
[TBL] [Abstract][Full Text] [Related]
37. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
Kane RC; Cashdollar MR; Bernath AM
Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554
[TBL] [Abstract][Full Text] [Related]
38. [Chemotherapy of metastasizing colonic carcinomas with nitrosourea compounts. Retrospective analysis].
Bombik BM; Oertel J; Schneider D; Gerhartz H
Onkologie; 1980 Apr; 3(2):49-52. PubMed ID: 6994004
[TBL] [Abstract][Full Text] [Related]
39. Two different schedules of irinotecan (CPT-11) in patients with advanced colorectal carcinoma relapsing after a 5-fluorouracil and leucovorin combination. A randomized study.
Tsavaris N; Ziras N; Kosmas C; Giannakakis T; Gouveris P; Vadiaka M; Dimitrakopoulos A; Karadima D; Rokana S; Papalambros E; Papastratis G; Margaris H; Tsipras H; Polyzos A
Cancer Chemother Pharmacol; 2003 Dec; 52(6):514-9. PubMed ID: 14504920
[TBL] [Abstract][Full Text] [Related]
40. Treatment of advanced colorectal cancer with a combination of 5-fluorouracil and methyl-CCNU.
Fischetti MR; Carey RW; Weitzman SA; Kaufman S; Kelley RM; Sohier WD
Med Pediatr Oncol; 1978; 4(3):277-8. PubMed ID: 683130
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
